Literature DB >> 20041380

Hip resurfacing through a modified anterolateral approach, as compared with the Ganz trochanteric flip osteotomy: a two year follow-up study.

Rashid M Khan1, Gillian Cooper, Jonathan B Hull.   

Abstract

Hip resurfacing arthroplasty has conventionally been undertaken through the posterior approach. There has been evidence in the recently published literature to suggest that the posterior approach may compromise the blood supply to the femoral head, by disruption of the posterolateral hip capsule. Ganz et al have proposed the trochanteric 'flip' osteotomy through a lateral approach, to permit surgical dislocation of the hip without damaging the blood supply. The disadvantages, however, are that early full weight bearing is not permitted and there is an incidence of trochanteric delayed or non-union, which may require further treatment. We describe a technique of hip resurfacing through a modified anterolateral approach preserving the posterolateral capsular blood supply. We describe our experience using this approach, and compare the results with our previously used Ganz trochanteric osteotomy. At a mean follow-up of two years, the outcome scores were not significantly different, and both groups had similar abductor strength. There were two cases of delayed union in the Ganz group, one of which required revision; there were no complications in the modified anterolateral group.

Mesh:

Year:  2009        PMID: 20041380     DOI: 10.1177/112070000901900407

Source DB:  PubMed          Journal:  Hip Int        ISSN: 1120-7000            Impact factor:   2.135


  2 in total

1.  Audit-induced change reduces complications of the Ganz trochanteric flip approach.

Authors:  P M Guyver; A Cattell; R P Reddy; C Edwards; D Williams; S M Dixon; M R Norton; E D Fern
Journal:  Ann R Coll Surg Engl       Date:  2010-07-02       Impact factor: 1.891

Review 2.  [Results of 5 to 10-year follow-up after hip resurfacing. A systematic analysis of the literature on long-term results].

Authors:  M C M Klotz; S J Breusch; M Hassenpflug; R G Bitsch
Journal:  Orthopade       Date:  2012-06       Impact factor: 1.087

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.